SCHEMBL259335

SCHEMBL259335

O=C(Nc1c(C(=O)O)oc2ncccc12)c1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.53
HPGD P15428 2/20 0.53
TP53 P04637 4/20 0.52
POLB P06746 1/20 0.52
MAPT P10636 3/20 0.46
RXFP1 Q9HBX9 1/20 0.46
F2 P00734 1/20 0.46
F12 P00748 1/20 0.46
PLAU P00749 1/20 0.46
KDR P35968 1/20 0.44
ADORA3 P0DMS8 2/20 0.43
NPC1 O15118 3/20 0.43
RAB9A P51151 3/20 0.43
PABPC1 P11940 1/20 0.42
TSHR P16473 2/20 0.41
HSD17B10 Q99714 2/20 0.41
AHR P35869 1/20 0.41
MAPK10 P53779 1/20 0.41
NAMPT P43490 1/20 0.41
KDM4E B2RXH2 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL259348 0.90 ALDH1A1 (0.66) ALDH1A1HPGDTP53POLBMAPT
SCHEMBL259192 0.87 MAPT (0.56) ALDH1A1TP53POLBMAPTRXFP1
SCHEMBL259344 0.86 KDR (0.50) ALDH1A1TP53POLBMAPTKDR
SCHEMBL14581998 0.83 HTT (0.57) ALDH1A1HPGDMAPTNPC1RAB9A
SCHEMBL259193 0.83 RAB9A (0.53) ALDH1A1TP53POLBMAPTKDR
SCHEMBL259026 0.79 HSD17B10 (0.42) ALDH1A1HPGDTP53MAPTRXFP1
SCHEMBL4565639 0.77 ALDH1A1 (0.60) ALDH1A1HPGDTP53POLBMAPT
SCHEMBL13298528 0.76 MAPT (0.56) ALDH1A1HPGDTP53MAPTRXFP1
SCHEMBL259353 0.74 MEN1 (0.70) ALDH1A1HPGDTP53MAPTRXFP1
SCHEMBL3728067 0.74 KDR (0.47) ALDH1A1HPGDPOLBMAPTKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8067586-B2 Fused heteroaryl derivatives ASTELLAS PHARMA INC. (JP) 2011-11-29 US disclosed
US-8067586-B2 Fused heteroaryl derivatives ASTELLAS PHARMA INC. (JP) 2011-11-29 US disclosed
US-20100137584-A1 FUSED HETEROARYL DERIVATIVES HAYAKAWA MASAHIKO 2010-06-03 US disclosed
US-20100137584-A1 FUSED HETEROARYL DERIVATIVES HAYAKAWA MASAHIKO 2010-06-03 US disclosed
US-20100137585-A1 FUSED HETEROARYL DERIVATIVES HAYAKAWA MASAHIKO 2010-06-03 US disclosed
US-20100137585-A1 FUSED HETEROARYL DERIVATIVES HAYAKAWA MASAHIKO 2010-06-03 US disclosed
US-20070037805-A1 Fused heteroaryl derivatives HAYAKAWA MASAHIKO 2007-02-15 US disclosed
US-20070037805-A1 Fused heteroaryl derivatives HAYAKAWA MASAHIKO 2007-02-15 US disclosed
US-7173029-B2 Fused heteroaryl derivatives ASTELLAS PHARMA INC. (JP) 2007-02-06 US disclosed
US-7173029-B2 Fused heteroaryl derivatives ASTELLAS PHARMA INC. (JP) 2007-02-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100137584-A1 FUSED HETEROARYL DERIVATIVES PIK3CD, PIK3R3, PIK3C2A ALDH1A1 4428/4885HPGD 4466/4885TP53 92/4885
US-20070037805-A1 Fused heteroaryl derivatives PIK3CD, PIK3R3, PIK3C2A ALDH1A1 4428/4885HPGD 4466/4885TP53 92/4885
US-20100137585-A1 FUSED HETEROARYL DERIVATIVES PIK3CD, PIK3R3, PIK3C2A ALDH1A1 4428/4885HPGD 4466/4885TP53 92/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.